Abstract

Pathogenic microbes are developing resistance to established antibiotics, making the development of novel antimicrobial molecules paramount. One major resource for discovery of antimicrobials is the arsenal of innate immunity molecules that are part of the first line of pathogen defense in many organisms. Gene encoded cationic antimicrobial peptides are a major constituent of innate immune arsenals. Many of these peptides exhibit potent antimicrobial activity in vitro. However, a major hurdle that has impeded their development for use in the clinic is the loss of activity at physiological salt concentrations, attributed to weakening of the electrostatic interactions between the cationic peptide and anionic surfaces of the microbial cells in the presence of salt. Using plant defensins we have investigated the relationship between the charge of an antimicrobial peptide and its activity in media with elevated salt concentrations. Plant defensins are a large class of antifungal peptides that have remarkable stability at extremes of pH and temperature as well as resistance to protease digestion. A search of a database of over 1200 plant defensins identified ZmD32, a defensin from Zea mays, with a predicted charge of +10.1 at pH 7, the highest of any defensin in the database. Recombinant ZmD32 retained activity against a range of fungal species in media containing elevated concentrations of salt. In addition, ZmD32 was active against Candida albicans biofilms as well as both Gram negative and Gram-positive bacteria. This broad spectrum antimicrobial activity, combined with a low toxicity on human cells make ZmD32 an attractive lead for development of future antimicrobial molecules.

Highlights

  • Over the last three decades, many issues have arisen that affect the sustainable use of antibiotics and antifungal drugs

  • ZmD32 was expressed in P. pastoris, purified by cation exchange and Reverse Phase-High Performance Liquid Chromatography (RP-HPLC) (Figure 1B)

  • One of the impediments to the development of antimicrobial peptides as pharmaceuticals is the substantial loss of activity at physiological salt concentrations

Read more

Summary

Introduction

Over the last three decades, many issues have arisen that affect the sustainable use of antibiotics and antifungal drugs. ZmD32, a Salt-Tolerant Plant Defensin antibiotics (Lynch and Robertson, 2008; Manavathu and Vazquez, 2017; Perlin et al, 2017). These challenges to the current therapeutic choices have led to a demand for novel drugs for the treatment of infectious diseases (Todd et al, 2009; Butts and Krysan, 2012; Perlin et al, 2017). The plant and animal kingdoms house a huge array of AMPs; only a small percentage of which have been characterized at the functional level

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.